Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic utility of cortactin antibodies in myasthenia gravis.

Annals of the New York Academy of Sciences - 1 Jan 2018

Illa Isabel, Cortés-Vicente Elena, Martínez María Ángeles, Gallardo Eduard

Abstract excerpt

Patients with myasthenia gravis (MG) without antibodies to the acetylcholine receptor (AChR) or muscle-specific tyrosine kinase (MuSK) have been classified as having double-seronegative myasthenia gravis (dSNMG). We used the sera from six dSNMG patients with positive immunohistochemistry assays in a protein array to screen reactivity with 9000 human proteins. We identified cortactin, an intracellular protein that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody Specificity
Share to Autoantibodies
Share to Autoantigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Models, Immunological

Share to Myasthenia Gravis

Share to Receptor Protein-Tyrosine Kinases

Share to Receptors, Cholinergic

Source

Identifiers

PMID: 29068555
DOI: 10.1111/nyas.13502

Genes

LRP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic utility of cortactin antibodies in myasthenia gravis.PMID 29068555Read ↗

Anti-Cortactin Autoantibodies Are Associated With Key Clinical Features in Adult Myositis But Are Rarely Present in Juvenile Myositis.Semantic proximity Read ↗

Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravisSemantic proximity Read ↗

Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia GravisSemantic proximity Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

Clinical utility of autoantibodies in the diagnosis and management of Myasthenia gravisSemantic proximity Read ↗

Distribution and Temporal Changes of Autoantibody-Mediated Pathogenic Mechanisms Among Acetylcholine Receptor-Positive Myasthenia Gravis PatientsSemantic proximity Read ↗

Timing and localization of myasthenia gravis-related gene expressionSemantic proximity Read ↗

The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junctionSemantic proximity Read ↗

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.Semantic proximity Read ↗

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.Semantic proximity Read ↗

A primary human muscle cell-based assay for detecting myasthenia gravis autoantibody binding and assessing AChR cluster impairmentSemantic proximity Read ↗

Different characteristic phenotypes according to antibody in myasthenia gravis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.